Forbes contributors publish independent expert analyses and insights. Jodie Cook covers AI, marketing & LinkedIn for coaches & entrepreneurs ...

The original version of this story appeared in Quanta Magazine. If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle ...

Kelley Cotter has received funding from the National Science Foundation. President Donald Trump announced on Sept. 19, 2025, a preliminary agreement for the sale of a majority stake in TikTok from ...

A deal between the U.S. and China over the ownership of TikTok includes new stipulations over who controls the social media company's algorithm, a closely guarded secret which has proved to be a major ...

Technology company Oracle will provide security for the new TikTok entity in the United States, following the President Trump-backed deal to allow the social media company to keep operating in the U.S ...

The White House has answered what had been one of the major outstanding questions regarding its pending deal to transfer TikTok’s US operations to a majority American ownership group: Under the ...

President Donald Trump announced on Sept. 19, 2025, a preliminary agreement for the sale of a majority stake in TikTok from Chinese tech giant ByteDance to a group of U.S. investors following Trump's ...

TikTok’s algorithm and board of directors will be “controlled by America” as part of a deal reached with China earlier this week, White House press secretary Karoline Leavitt said Saturday, following ...

There is a new sorting algorithm a deterministic O(m log2/3 n)-time algorithm for single-source shortest paths (SSSP) on directed graphs with real non-negative edge weights in the comparison-addition ...

If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle the easiest pieces first. But this kind of sorting has a cost.

Recursion Pharmaceuticals is now the sole owner of a drug in its pipeline. The deal de-risks the company's pipeline by removing uncertainty; however, there's still a long way to go before REV102 is ...

Recursion Pharmaceuticals is now the sole owner of a drug in its pipeline. The deal de-risks the company's pipeline by removing uncertainty; however, there's still a long way to go before REV102 is ...